Positive Expiratory Pressure Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Face Mask PEP Devices, Mouthpiece PEP Devices, Bottle PEP Devices); Pressure Type (High Pressure PEP (26-102cm H2O), Low-Pressure PEP (5-20cm H2O)); Application (Atelectasis, Bronchiectasis, Bronchitis, Cystic Fibrosis, Asthma, COPD); End User (Hospital And Clinics, Ambulatory Surgical Centers, Others)
Report Code: TIPRE00015241
| No. of Pages: 150
| Category: Medical Device
| Status: Upcoming
Positive expiratory pressure therapy (PEP) is used for airway clearance therapy. In this therapy, a person breathes through a handheld mouthpiece or mask. This helps air to get behind the mucus in the lungs and move it from the airway walls. The device allows air to pass freely, and involves active expiration of the inhaled air against the resistance.
The positive expiratory pressure devices market is driving due to rise in prevalence of COPD owing to the increase in smoking and drinking in developed countries, and the recent launches of novel oscillatory PEP. However, lack of awareness about technologically advanced airway clearance therapies in low-income countries is expected to hamper the growth of the global Positive Expiratory Pressure Devices market. Moreover, time consuming traditional methods of airway clearance is anticipated to drive demand the growth of the market.
The "Positive Expiratory Pressure Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of positive expiratory pressure devices market with detailed market segmentation by product type, pressure type, application, and end user. The positive expiratory pressure devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in positive expiratory pressure devices market and offers key trends and opportunities in the market.
The positive expiratory pressure devices market is segmented on the basis of product type, pressure type, application, and distribution channel. On the basis of product type, the market is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. Based on pressure type, the global positive expiratory pressure device market is segmented into high pressure PEP (26-102cm H2O) and low-pressure PEP (5-20cm H2O). On the basis of application, the market is segmented into atelectasis, bronchiectasis, bronchitis, cystic fibrosis, asthma, and COPD. On the basis of end user, the market is segmented into hospital and clinics, ambulatory surgical centers, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the positive expiratory pressure devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The positive expiratory pressure devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting positive expiratory pressure devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the positive expiratory pressure devices market in these regions.
Get more information on this report :
The report covers key developments in the positive expiratory pressure devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from positive expiratory pressure devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for positive expiratory pressure devices market in the global market. Below mentioned is the list of few companies engaged in the Positive Expiratory Pressure Devices market.
The report also includes the profiles of key players in positive expiratory pressure devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Aptalis Pharma US, Inc.
Koninklijke Philips N.V.
Monaghan Medical Corporation
D- R BURTON HEALTHCARE
WyMedical Pty Ltd
Medica Holdings, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
1. Smiths Medical
2. Aptalis Pharma US, Inc.
3. Koninklijke Philips N.V.
4. Monaghan Medical Corporation
5. D- R BURTON HEALTHCARE
7. PARI GmbH
8. CEGLA Medizintechnik
9. WyMedical Pty Ltd
10. Medica Holdings, Inc.